Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-034610

Chief Business Officer bought 2,500 shares at $9.08 ($22,708)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Desmarais William Chief Business Officer 2021-08-27 Purchase +2,500 $9.08 $22,708 2,500 D: show line 1 in the form
Open-market purchases · 2,500 sh · avg $9.08 · $22,708
Loading xslF345X03/doc4.xml…